TIGIT promotes CD8+T cells exhaustion and predicts poor prognosis of colorectal cancer
- 30 September 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Immunology, Immunotherapy
- Vol. 70 (10), 2781-2793
- https://doi.org/10.1007/s00262-021-02886-8
Abstract
TIGIT is a lymphocyte surface receptor, which is mainly expressed on the surface of CD8(+)T cells. The role of TIGIT in colorectal cancer and its expression pattern in colorectal cancer infiltrating lymphocytes are still controversial. This study aimed at identifying the function of TIGIT in colorectal cancer. Patients with colorectal cancer showed significantly higher TIGIT(+)CD8(+)T cell infiltration in tumor tissues, metastases compared with paired PBMC and normal tissues through flow cytometry. TIGIT(+)CD8(+)T cells showed an exhausted phenotype and expressed low levels of killer cytokines IFN-gamma, IL-2, TNF-alpha. In addition, more inhibitory receptors such as PD-1, LAG-3, and TIM-3 were expressed on the surface of TIGIT(+)CD8(+)T cells. TGF-beta 1 could promote the expression of TIGIT and inhibit CD8(+)T cell function in vitro. Moreover, the accumulation of TIGIT(+)T cells in tumors was associated with advanced disease, predicted early recurrence, and reduced survival rates in colorectal cancer patients. Our results indicate that TIGIT can be a biological marker for the prognosis of colorectal cancer, and TIGIT can be used as a potential target for treatment.Funding Information
- the science and technology planning project of Guangdong province (2017B020227009)
This publication has 44 references indexed in Scilit:
- The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non–Small Cell Lung CancerJournal of Thoracic Oncology, 2016
- Cancer immunotherapy: harnessing the immune system to battle cancerJCI Insight, 2015
- The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector FunctionCancer Cell, 2014
- Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell ResponsesImmunity, 2014
- Innate and adaptive immune cells in the tumor microenvironmentNature Immunology, 2013
- The TIGIT/CD226 Axis Regulates Human T Cell FunctionThe Journal of Immunology, 2012
- T cell exhaustionNature Immunology, 2011
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progressionTrends in Immunology, 2010
- The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cellsNature Immunology, 2008
- Replicative senescence of CD8 T cells: potential effects on cancer immune surveillance and immunotherapyCancer Immunology, Immunotherapy, 2004